A metabolic biosignature of early response to anti-tuberculosis treatment

BACKGROUND: The successful treatment of tuberculosis (TB) requires long-term multidrug chemotherapy. Clinical trials to evaluate new drugs and regimens for TB treatment are protracted due to the slow clearance of Mycobacterium tuberculosis (Mtb) infection and the lack of early biomarkers to predict...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mahapatra, Sebabrata, Hess, Ann M, Johnson, John L, Eisenach, Kathleen D, DeGroote, Mary A, Gitta, Phineas, Joloba, Moses L, Kaplan, Gilla, Walzl, Gerhard, Boom, W Henry, Belisle, John T
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2014
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3918231/
https://ncbi.nlm.nih.gov/pubmed/24484441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-14-53
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados